PhRMA Statement on HHS and CMS Nominees
Washington, D.C. (November 29, 2016) — Pharmaceutical Research and Manufacturers of America (PhRMA) president and CEO, Stephen J. Ubl, issued the following statement:
“PhRMA congratulates Chairman Tom Price, M.D. on his nomination as Secretary of Health and Human Services. His vast health care experience and knowledge will be a great asset to the Agency. PhRMA also congratulates Seema Verma on her nomination to lead the Center for Medicare and Medicaid Services. We look forward to working with Dr. Price and Ms. Verma in their new roles to ensure patients can access the medicines they need to help them live longer, healthier lives.”
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. Since 2000, PhRMA member companies have invested more than half a trillion dollars in the search for new treatments and cures, including an estimated $58.8 billion in 2015 alone.
Connect with PhRMA
For information on how innovative medicines save lives, please visit: